AuriPro: Completed Phase II enrollment

Otonomy completed enrollment of 39 pediatric patients in a 1-month, open-label, U.S. Phase II trial evaluating a single dose of 6 mg AuriPro. On April 28, FDA accepted for review an NDA for AuriPro to...